183 related articles for article (PubMed ID: 9052761)
1. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
Baert JL; Monté D; Musgrove EA; Albagli O; Sutherland RL; de Launoit Y
Int J Cancer; 1997 Mar; 70(5):590-7. PubMed ID: 9052761
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the PEA3 subfamily of ETS transcription factors in the mouse ovary and peri-implantation uterus.
Koo TB; Song H; Moon I; Han K; Chen C; Murphy K; Lim H
Reproduction; 2005 May; 129(5):651-7. PubMed ID: 15855628
[TBL] [Abstract][Full Text] [Related]
5. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
[TBL] [Abstract][Full Text] [Related]
6. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
[TBL] [Abstract][Full Text] [Related]
7. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.
Kurpios NA; Sabolic NA; Shepherd TG; Fidalgo GM; Hassell JA
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):177-90. PubMed ID: 14635793
[TBL] [Abstract][Full Text] [Related]
8. [PEA3 family of transcription factors and the regulation of oncogenesis].
de Launoit Y; Baert JL; Chotteau-Lelievre A; Monte D; Coutte L; Mauen S; Firlej V; Degerny C; Verreman K
Bull Cancer; 2006 Oct; 93(10):985-9. PubMed ID: 17074657
[TBL] [Abstract][Full Text] [Related]
9. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
[TBL] [Abstract][Full Text] [Related]
10. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
[TBL] [Abstract][Full Text] [Related]
11. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.
de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL
Adv Exp Med Biol; 2000; 480():107-16. PubMed ID: 10959416
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.
Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC
Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
14. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
15. [Transcription factors of the PEA3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract][Full Text] [Related]
16. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM
Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322
[TBL] [Abstract][Full Text] [Related]
17. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
18. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.
Bièche I; Tozlu S; Girault I; Onody P; Driouch K; Vidaud M; Lidereau R
Carcinogenesis; 2004 Mar; 25(3):405-11. PubMed ID: 14633660
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells.
Barrett JM; Puglia MA; Singh G; Tozer RG
Breast Cancer Res Treat; 2002 Apr; 72(3):227-32. PubMed ID: 12058964
[TBL] [Abstract][Full Text] [Related]
20. PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.
Gu S; Chen L; Hong Q; Yan T; Zhuang Z; Wang Q; Jin W; Zhu H; Wu J
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):771-8. PubMed ID: 21831961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]